Answer
The most frequently reported side effects in clinical trials of Increlex (mecasermin) in patients with IGF-1 deficiency were headache (44%), hypoglycaemia (28%), vomiting (26%), injection site hypertrophy (17%) and otitis media (17%).
Sources for this answer
- Increlex 10 mg/ml solution for injectionEsteve Pharmaceuticals (formerly Intrapharm Laboratories) · emc · SmPC §4.8 Undesirable effects · Version 2Document updated
Sources checked